Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study

Telomerase reverse transcriptase (TERT) promoter mutations are the most frequent genetic events in bladder cancer (BC). The aim of the present pilot study was to evaluate the diagnostic potential of urine TERT promoter mutations-based liquid biopsy in patients with an ongoing oncological process, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Mark, Kamalov, David, Tivtikyan, Alexander, Balatsky, Alexander, Samokhodskaya, Larisa, Okhobotov, Dmitry, Kozlova, Polina, Pisarev, Eduard, Zvereva, Maria, Kamalov, Armais
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548999/
https://www.ncbi.nlm.nih.gov/pubmed/34712485
http://dx.doi.org/10.3892/mco.2021.2415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548999/
https://www.ncbi.nlm.nih.gov/pubmed/34712485
http://dx.doi.org/10.3892/mco.2021.2415

Ejemplares similares